ChinaAMC CSI Robot ETF (562500) falls 4.27%, with the latest margin financing purchase amount reaching 64.6893 million yuan
NewTimeSpace (newtimespace.com) News, as of 11:14 on June 22, 2026, ChinaAMC Robot ETF (562500) fell 4.27%, with the latest price at 1.12 yuan. Over a longer time frame, as of June 18, 2026, the ETF accumulated a gain of 7.64% over the past week. (The stocks listed above are only index constituents and do not constitute any specific recommendation.)
In terms of liquidity, ChinaAMC Robot ETF recorded an intraday turnover rate of 4.28% and a trading volume of 776 million yuan. Over a longer time frame, as of June 18, the ETF's average daily trading volume over the past month reached 1.242 billion yuan, ranking first among comparable funds.
In terms of scale, ChinaAMC Robot ETF saw a significant increase of 343 million yuan in scale over the past week, with the new scale increase ranking 1/9 among comparable funds. (Data source: Wind)
Data shows that leveraged funds are continuously positioning. The latest margin financing purchase amount of ChinaAMC Robot ETF reached 64.6893 million yuan, with the latest margin financing balance standing at 620 million yuan. (Data source: Wind)
As of June 18, the net value of ChinaAMC Robot ETF rose by 73.74% over the past two years, ranking in the top 2 among comparable funds. From the perspective of return capability, as of June 18, 2026, since its inception, the ETF achieved a highest single-month return of 26.22%, a longest streak of consecutive up months of 4 months, a maximum cumulative gain during that streak of 32.14%, a ratio of up months to down months of 28/25, an average return of 7.53% in up months, an annual positive return percentage of 75.00%, and a probability of positive return after a 3-year holding period of 91.46%. As of June 18, 2026, the ETF's annualized excess return over its benchmark since inception was 1.74%.
As of June 18, 2026, the one-year Sharpe ratio of ChinaAMC Robot ETF was 1.35.
In terms of drawdown, as of June 18, 2026, ChinaAMC Robot ETF recorded a drawdown of 0.49% relative to its benchmark since the beginning of the year. The number of days to recover after the drawdown was 49 days, reflecting relatively fast recovery among comparable funds.
In terms of fees, ChinaAMC Robot ETF has a management fee rate of 0.50% and a custodian fee rate of 0.10%, the lowest fee rates among comparable funds.
In terms of tracking accuracy, as of June 18, 2026, the three-year tracking error of ChinaAMC Robot ETF was 0.030%, achieving the highest tracking accuracy among comparable funds.
ChinaAMC Robot ETF closely tracks the CSI Robot Index. The CSI Robot Index selects the securities of listed companies that are system solution providers, digital workshop and production line system integrators, automation equipment manufacturers, automation parts suppliers, and other robot-related companies as index constituents, in order to reflect the overall performance of robot-related securities among listed companies.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- AI Chip Concept Stocks Watch | ASMPT (00522.HK) Fluctuates and Decreases; Institutions Point Out Domestic AI Chips Are Welcoming a Price Hike Window
- iShares CSI 300 A-Share Index ETF(02846.HK) Rises 1.09% Intraday, AUM Reaches HK$8.462 Billion
- SIHUAN PHARM(00460.HK): First Patient Dosed in Phase III Trial of Anaprazole Sodium from Xuanzhu Biologics for Helicobacter Pylori Eradication
- Db X-Trackers FTSE Vietnam UCITS ETF(03087.HK) Rises 0.90% Intraday at HK$326.80
- INNOGEN-B(02591.HK): Ib-stage Clinical Trial of Efsubaglutide Alfa for Adolescent Obesity Approved, Expected to Kick Off in July